Pancreatic Cancer

Expert insights on pancreatic cancer, focusing on evolving treatment strategies and clinical decision-making across disease stages.

Pancreatic Cancer

Two medical professionals, a woman and a man, in white coats with a city skyline background, discussing RAS-targeted therapy in pancreatic adenocarcinoma.

Pancreatic Cancer

06/19/2026

Daraxonrasib and the Future of RAS Inhibitors in Pancreatic Cancer

Antonella Cammarota, PhDMichael May, MD

Panel discussion on managing toxicity and expanding RAS therapy in pancreatic cancer featuring Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr. Shu.

Pancreatic Cancer

06/16/2026

Managing Toxicity and Expanding RAS Therapy in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Panel of oncology experts discussing the clinical impact of RASolution 302 in doubling patient survival.

Pancreatic Cancer

06/15/2026

Doubling Survival: The Clinical Impact of RASolute 302

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Panel discussion on drug development and clinical success in RAS-driven cancer, featuring experts Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr.

Pancreatic Cancer

06/14/2026

From Drug Design to Phase 3 Success in RAS-Driven Disease

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBA

Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, Dr. Shubham Panti discuss Daraxonrasib's impact on pancreatic cancer survival.

Pancreatic Cancer

06/13/2026

Daraxonrasib Delivers Breakthrough Survival Gains in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Panel of medical experts discussing the impact of RASolute 302 on clinical practice for metastatic pancreatic ductal adenocarcinoma (PDAC).

Pancreatic Cancer

06/02/2026

Clinical Insights: Impact of RASolute 302 on Clinical Practice in Previously Treated Metastatic PDAC

Andrew H. Ko, MDShubham Pant, MD, MBBSEileen O'Reilly, MDRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD

Advanced medical professionals discussing treatment considerations and safety updates in metastatic pancreatic adenocarcinoma, with a cityscape background emphasizing healthcare expertise and research.

Pancreatic Cancer

03/10/2026

Treatment Considerations and Safety Updates in Metastatic Pancreatic Adenocarcinoma

Rahul Gosain, MD, MBARohit Gosain, MD

Advances in pancreatic and biliary tract cancers at ASCO GI 2026, expert insights, oncology research, cancer treatment innovations, medical conference, OncUpdates.

Pancreatic Cancer

02/08/2026

Advances in Pancreatic and Biliary Tract Cancers at ASCO GI 2026: Expert Insights

Anupriya Singhal, MD, PhD

1. Emerging targeted and combination strategies in pancreatic cancer for improved treatment outcomes, featuring experts Angelo Pirozzi, MD, and Fiyinfolu Balogun, MD, PhD, against San Francisco skyline backdrop.

Pancreatic Cancer

01/23/2026

Pancreatic Cancer Highlights From ASCO GI 2026

Fiyinfolu Balogun, MD, PhDAngelo Pirozzi, MD

N/A.

Pancreatic Cancer

01/20/2026

Optimal Frontline Treatment in Metastatic Pancreatic Cancer

Raji Shameem, MDRohit Gosain, MD

KRAS inhibitors, targeted therapy, GI oncology, cancer treatment, molecular targeted therapy, cancer research, precision medicine, oncology advancements, clinical oncology, cancer therapy innovation.

Pancreatic Cancer

01/19/2026

Molecular Profiling Expands Treatment Options in Pancreatic and Biliary Tract Cancers

Dina Ioffe, MDShubham Pant, MD, MBBS

Inflammation in the pancreas indicating pancreatic cancer, with an anatomical focus on the abdomen, digital medical illustration, highlighting key areas associated with pancreatic tumors and gastrointestinal health.

Pancreatic Cancer

01/07/2026

Pancreatic Cancer in 2025: Nearing an Inflection Point

Udhayvir Singh Grewal, MD

Expert medical professionals discuss cancer treatment advances at an oncology conference, emphasizing personalized medicine and innovative research in cancer care.

Pancreatic Cancer

06/10/2025

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBSLisa Liu, MD

Managing side effects of pancreatic cancer treatment with expert insights from oncologists and latest research updates on ToxCheck.

Pancreatic Cancer

05/28/2025

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MDRachna Shroff, MD, MS, FASCO